Independent laboratory testing of Grignard Pure® performance in occupied and unoccupied environments.

Research examining the efficacy and safety of aerosolized triethylene glycol in indoor environments.

Research examining the testing methods used to accurately evaluate antimicrobial air treatment efficacy.

A report on the performance and efficacy of Grignard Pure® against an array of pathogens including viruses (MS2 and PHI 6 surrogates), bacteria (MRSA, salmonella, mycobacterium, and others), and mold (aspergillus) as conducted by Aerosol Research Laboratories, Inc.

This report documents how aerosolized microorganisms are distributed homogeneously throughout the 16 m³ bioaerosol test chamber. The study demonstrates with a high degree of confidence that samples collected from any of the four designated sampling ports are statistically equivalent and representative of the entire chamber environment. Successful validation is critical to ensuring the consistency, accuracy, and reliability of all client and internal bioaerosol testing projects. 

Statistical analysis evaluating the efficacy of Grignard Pure® against aerosolized microorganisms.

TLV Assessment of Triethylene Glycol, December 2024

Grignard Pure time-controlled release against Staphylococcus epidermitis March 23, 2026

Grignard Pure time-controlled release against Pseudomonas flourescens March 23, 2026